MedTrace Logo

Clinical Investigation Plan for IQon Spectral CT at Utrecht Medical Center (UMC)

NCT02747095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 980

Last updated 2017-08-01

No results posted yet for this study

Summary

The CT examination on IQon Spectral CT would be a standard of care CT performed as per the clinical indication. The conventional CT images generated by the scanner will be used for clinical purposes as routinely practiced. And therefore, the primary study aim is to assess the impact of IQon Spectral CT scanner and applications on the clinical workflow of the site as well as the diagnostic confidence levels of the physicians reading the CT cases.

In addition to the aim mentioned above, the investigators would like to develop recommendations for the clinical application of the spectral images in routine use. Such recommendations could include optimization of scanning protocols, optimization of reconstruction parameters; evaluate the utility of iodine maps and other supported materials.

Conditions

  • Artery
  • Deformity
  • Coronary (Acquired)

Interventions

DEVICE

IQon Spectral CT

Using IQon Spectral CT, Assess the added diagnostic value and impact on workflow of spectral images

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • Philips Healthcare

    lead INDUSTRY

Principal Investigators

  • Tim Leiner · Utrect Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-04-28
Completion
2017-04-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02747095 on ClinicalTrials.gov